img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
December 1, 2020
img
img
CEL-SCI Corporation
(NYSE: CVM)

$14,650,000

Bought Underwritten Public Offering
Joint Bookrunner

December 1, 2020
img
img
Ontrak, Inc.
(Nasdaq: OTRK)

$42,817,500

Follow-On Offering
Co-Manager

December 1, 2020
img
img
GreenBox POS
(OTCQB: GRBX)

$3,200,000

Private Placement
Exclusive Placement Agent

December 1, 2020
img
img
Monaker Group
(Nasdaq: MKGI)

$8,855,000

Bought Underwritten Public Offering
Joint Bookrunner

November 1, 2020
img
img
U.S. Energy Corp.
(Nasdaq: USEG)

$3,450,000

Follow-On Offering
Sole Bookrunner

November 1, 2020
img
img
Taronis Fuels, Inc.
(OTCQB: TRNF)

$10,425,000

Private Placement
Exclusive Placement Agent

November 1, 2020
img
img
Dragon Victory International Limited
(Nasdaq: LYL)

$1,500,000

Private Placement
Exclusive Placement Agent

November 1, 2020
img
img
Kingswood Acquisition Corp.
(NYSE: KWAC)

$115,000,000

SPAC IPO
Issuer

October 1, 2020
img
Presidio Property Trust
(Nasdaq: SQFT)

$2,500,000

Initial Public Offering
Sole Bookrunner

October 1, 2020
img
American Resources Corp.
(Nasdaq: AREC)

$13,000,000

Registered Direct
Exclusive Placement Agent

October 1, 2020
img
img
Gladstone Land Corp.
(Nasdaq: LAND)

$23,760,000

Follow-On Offering
Co-Manager

October 1, 2020
img
Molecular Data Inc.
(Nasdaq: MKD)

$5,000,000

Private Placement
Exclusive Placement Agent

1 … 29 30 31 32 33 … 35
Insights
  • May 22, 2025

    D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ: LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering

    Read More icon Read More icon
  • May 13, 2025

    D. Boral Capital Acted as Capital Markets Advisor to Global Star Acquisition Inc. (NYSE: GLST) in connection with its Completed Business Combination with K Enter Holdings Inc.

    Read More icon Read More icon
  • May 12, 2025

    D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering

    Read More icon Read More icon
  • May 7, 2025

    D. Boral Capital is Acting as Exclusive Placement Agent to Nature’s Miracle Holding Inc. (OTCQB: NMHI) in connection with its Private Placement for up to $20 Million

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.